IMP4 Silencing Inhibits the Malignancy of Lung Adenocarcinoma via ERK Pathway

Figure 1

High IMP4 expression was found in LUAD and suggested association with poor prognosis for LUAD patients. (a) The differential levels of IMP4 across TCGA cancers. (b) The expression of IMP4 in LUAD was analysed using UALCAN based on TCGA database. (c) The survival curves of LUAD patients from GEPIA database. (d) Immunohistochemistry was applied to assess IMP4 levels in LUAD tissues. (d) The expression of IMP4 in 16HBE, NCI–H1975, H1299, A549, and H23 cells was determined using Western blotting.

(a)

(b)

(c)

(d)

(e)